check
The essentiality of genes in cancer cell lines is influenced by the presence of sex chromosomes. | Sagiv Shifman Lab

The essentiality of genes in cancer cell lines is influenced by the presence of sex chromosomes.

23 October, 2022

Men and women differ in various aspects, including disease occurrence, symptom frequency, and response to different medications. For instance, certain types of cancer are more prevalent in men, and treatment outcomes may vary between women and men with the same tumor type. What factors can explain these disparities?

The primary biological mechanisms responsible for sex-based differences in humans are sex hormones and sex chromosomes (X and Y). However, it is challenging to isolate their individual effects in humans since males typically possess both a Y and an X chromosome (XY) along with male hormone secretion, while females have two X chromosomes (XX) and higher levels of female hormones. Demonstrating the direct influence of sex chromosomes separate from hormones is complex.

A pivotal question in our research is the extent to which sex chromosomes contribute to sex differences at the cellular level.

In a recently published study in Genome Research, we utilized the tendency of cancer cell lines to undergo sex chromosome loss or duplication. We successfully determined the number of sex chromosomes in 355 cancer cell lines from women and 408 from men. The majority of cell lines fell into four categories: normal cells from an XX female and an XY male, cells from a female with one X chromosome lost (X0), cells from a male with the Y chromosome lost (X0).

By using these cell groups, we investigated how sex chromosomes influence gene expression and the essentiality of genes across the genome. In addition to changes in gene expression, we identified genes where mutations had varying effects based on the composition of sex chromosomes in the cells. The most pronounced impact was observed in genes on the X chromosome that had a similar counterpart (paralogous gene) on the Y chromosome. The mutation had a more detrimental effect in cells lacking a Y chromosome. This may be because paralogous genes on the Y chromosome can perform similar functions and compensate for the absence of the gene on the X chromosome.

Furthermore, we conducted a comparison of somatic mutations (mutations occurring in some cells of the body during a lifetime) in an extensive collection of cancer tumors from both men and women. We identified 21 genes on the X chromosome that exhibited a bias in mutation frequency between cancer tumors in men and women. Notably, all these genes had paralogs on the Y chromosome. We also observed that genes with paralogs on the Y chromosome tended to have an increased number of mutations in men but fewer mutations in tumors originating from women. This observation supports the notion that genes on the X chromosome with a paralog on the Y chromosome are more resilient to mutations in males.

Our findings demonstrate that both X and Y chromosomes exert a global influence on gene expression and gene viability. Besides shedding light on the differences between males and females, these results have implications for understanding syndromes involving changes in sex chromosomes and the loss of the Y chromosome, which are frequently observed in cancer cells and during the natural aging process in men.

Read more about this research here:

https://genome.cshlp.org/content/32/11-12/1993.short